Inhibitor Therapeutics's total assets for Q2 2026 were $637.19K, a decrease of -55.55% from the previous quarter. INTI total liabilities were $3.20M for the fiscal quarter, a -6.31% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.